Dublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- "Cat Therapeutic Diet Market Size, Share & Trends Analysis Report by Product, Indication, Distribution Channel, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.
The global cat therapeutic diet market was valued at an estimated USD 1.8 billion in 2025 and is projected to reach USD 3.6 billion by 2033, expanding at a CAGR of 8.9% from 2026 to 2033. Market growth is being supported by innovation in specialized pet nutrition, the rising prevalence of chronic feline diseases, and increasing demand for high-quality, scientifically formulated diets.
Advances in microbiome science are accelerating the development of condition-specific cat food formulations. At the Veterinary Meeting & Expo 2025, Hill's Pet Nutrition presented new and enhanced Prescription Diet and Science Diet products featuring ActivBiome+ technology. Supported by extensive microbiome research involving thousands of biological samples, the technology enables targeted nutritional support for digestive, renal, immune, and organ health. Key formulations include ActivBiome+ Digestion, ActivBiome+ Kidney Defense, and Multi-Benefit blends.
The growing incidence of obesity and nutrition-related disorders is also increasing demand for therapeutic cat diets. According to an October 2025 article published by SKS Veterinary Hospital, obesity prevalence among companion animals in urban environments is estimated at 35-40%. The condition is associated with metabolic dysfunction, hormonal imbalance, diabetes, joint disorders, and cardiovascular complications. Approximately 35% of cat owners already include therapeutic or prescription diets in pet weight-loss programs, highlighting further potential for clinically formulated weight-management products.
Diabetes represents another important market driver. Merck & Co., Inc. reports that the condition affects approximately 1 in 230 cats. Long-term management typically combines veterinary supervision with specialized nutrition, creating sustained demand for diabetic care diets. As diagnostic rates and veterinary awareness improve, diet-based management of obesity, diabetes, renal disease, gastrointestinal disorders, and related chronic conditions is expected to gain wider adoption.
Pet insurance is further improving access to veterinary-led nutrition. Policies offered through Asda Money cover eligible consultations, diagnostics, medications, and treatments for new illnesses or injuries. Certain plans also provide limited coverage for specialist or prescribed diet food under veterinary benefits. This can reduce the financial burden associated with therapeutic diets prescribed for gastrointestinal conditions, renal disease, allergies, and other health concerns.
Market Segmentation
The report provides global, regional, and country-level revenue forecasts and analyzes industry trends across key sub-segments from 2021 to 2033. Market segmentation covers product, indication, distribution channel, and region.
- Product: Wet Food, Dry Food, and Others
- Indication: Renal Care, Obesity Care, Diabetic Care, Dental Care, Gastrointestinal Care, Recovery Care, Joint Care, Oncology Care, and Others
- Distribution Channel: E-commerce, Veterinary hospitals & clinics, Retail Pharmacies, and Others
Regional Coverage
- North America: U.S., Canada, and Mexico
- Europe: UK, Germany, France, Italy, Spain, Denmark, Sweden, and Norway
- Asia Pacific: Japan, China, India, Australia, Thailand, and South Korea
- Latin America: Brazil and Argentina
- Middle East & Africa: South Africa, UAE, Saudi Arabia, Kuwait, Qatar, and Oman
Strategic Value of the Report
- Detailed analysis of the cat therapeutic diet market across major segments and geographic regions
- Revenue estimates and forecasts to support market assessment and investment planning
- Evaluation of emerging trends, growth drivers, and commercial opportunities
- Competitive intelligence covering key participants, market presence, and strategic positioning
- Insight into product innovation and condition-specific nutritional developments
- Actionable recommendations designed to identify revenue opportunities and support informed business decisions
The report equips manufacturers, veterinary nutrition companies, retailers, investors, and other stakeholders with market intelligence for strategic planning. Its analysis of therapeutic cat food trends, regional demand, distribution channels, clinical nutrition innovation, and competitive activity supports effective decision-making in a rapidly expanding global market.
Key Attributes
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Forecast Period | 2025-2033 |
| Estimated Market Value (USD) in 2025 | $1.8 Billion |
| Forecasted Market Value (USD) by 2033 | $3.6 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
Companies Featured
- Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
- Nestle
- Mars Petcare (Royal Canin)
- General Mills Inc. (Blue Buffalo Company, Ltd.)
- Diamond Pet Foods, Inc.
- Virbac
- VNG (Veterinary Nutrition Group)
- Farmina Pet Foods USA
- EmerAid
- TROVET
For more information about this report visit https://www.researchandmarkets.com/r/y5kviv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

